292 related articles for article (PubMed ID: 9576951)
1. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.
Nagane M; Levitzki A; Gazit A; Cavenee WK; Huang HJ
Proc Natl Acad Sci U S A; 1998 May; 95(10):5724-9. PubMed ID: 9576951
[TBL] [Abstract][Full Text] [Related]
2. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
[TBL] [Abstract][Full Text] [Related]
3. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
[TBL] [Abstract][Full Text] [Related]
5. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
6. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications.
Nagane M; Lin H; Cavenee WK; Huang HJ
Cancer Lett; 2001 Jan; 162 Suppl():S17-S21. PubMed ID: 11164186
[TBL] [Abstract][Full Text] [Related]
7. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.
Kojima H; Endo K; Moriyama H; Tanaka Y; Alnemri ES; Slapak CA; Teicher B; Kufe D; Datta R
J Biol Chem; 1998 Jul; 273(27):16647-50. PubMed ID: 9642215
[TBL] [Abstract][Full Text] [Related]
9. Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells.
Simizu S; Umezawa K; Takada M; Arber N; Imoto M
Exp Cell Res; 1998 Jan; 238(1):197-203. PubMed ID: 9457072
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
Lamothe B; Aggarwal BB
J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
[TBL] [Abstract][Full Text] [Related]
14. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
Srinivasan A; Li F; Wong A; Kodandapani L; Smidt R; Krebs JF; Fritz LC; Wu JC; Tomaselli KJ
J Biol Chem; 1998 Feb; 273(8):4523-9. PubMed ID: 9468507
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.
Medema JP; Scaffidi C; Krammer PH; Peter ME
J Biol Chem; 1998 Feb; 273(6):3388-93. PubMed ID: 9452459
[TBL] [Abstract][Full Text] [Related]
18. Type I insulin-like growth factor receptor activation regulates apoptotic proteins.
Singleton JR; Dixit VM; Feldman EL
J Biol Chem; 1996 Dec; 271(50):31791-4. PubMed ID: 8943217
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
[TBL] [Abstract][Full Text] [Related]
20. ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain.
Yiin JJ; Hu B; Schornack PA; Sengar RS; Liu KW; Feng H; Lieberman FS; Chiou SH; Sarkaria JN; Wiener EC; Ma HI; Cheng SY
Mol Cancer Ther; 2010 Apr; 9(4):929-41. PubMed ID: 20371720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
